A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab (Avastin) Plus Platinum And Paclitaxel or With Pemetrexed Plus Platinum in Patients With Non-Squamous Non-Small Cell Lung Cancer

NCT01496742 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

259

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Squamous Non-Small Cell Lung Cancer

Interventions

DRUG: Placebo
DRUG: RO5490258
DRUG: bevacizumab [Avastin]
DRUG: cisplatin/carboplatin
DRUG: paclitaxel
DRUG: pemetrexed

Sponsor

Genentech, Inc.